Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.66 - $1.81 $6,600 - $18,100
-10,000 Reduced 50.0%
10,000 $8,000
Q3 2020

Nov 12, 2020

SELL
$2.77 - $6.17 $55,400 - $123,400
-20,000 Reduced 50.0%
20,000 $57,000
Q1 2020

May 13, 2020

BUY
$0.73 - $1.91 $21,900 - $57,300
30,000 Added 300.0%
40,000 $38,000
Q1 2019

Apr 26, 2019

BUY
$1.54 - $2.01 $15,400 - $20,099
10,000 New
10,000 $19,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.